Cover Image

PP 5.3 - 00115 Chemical inhibition of DPP9 sensitizes CARD8 inflammasomes in HIV-1-infected cells

Saved in:

Bibliographic Details
Main Authors:	K. Clark (Author), J. Kim (Author), Q. Wang (Author), H. Gao (Author), R. Presti (Author), L. Shan (Author), A.M. Bursky (Author), J.M. Bursky (Author)
Format:	Book
Published:	Elsevier, 2022-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

PP 1.21 - 00118 Regulation of HIV-1 persistence by the CARD8 inflammasome
by: L. Shan, et al.
Published: (2022)

Chemical Variations on the p53 Reactivation Theme
by: Carlos J. A. Ribeiro, et al.
Published: (2016)

Establishment of a selective evaluation method for DPP4 inhibitors based on recombinant human DPP8 and DPP9 proteins
by: Jinglong Liu, et al.
Published: (2014)

Cooking behaviours after Diabetes Prevention Program (DPP) participation among DPP participants in Baltimore, MD
by: Lauren E Russell, et al.
Published: (2023)

The Roles of Dipeptidyl Peptidase 4 (DPP4) and DPP4 Inhibitors in Different Lung Diseases: New Evidence
by: Tianli Zhang, et al.
Published: (2021)

Renoprotective Effects of DPP-4 Inhibitors
by: Daiji Kawanami, et al.
Published: (2021)

A dipeptidyl peptidase-4 (DPP-4) inhibitor, linagliptin, attenuates cardiac dysfunction after myocardial infarction independently of DPP-4
by: Takehiro Yamaguchi, et al.
Published: (2019)

Multiple Chemical Sensitivity in Chemical Laboratory Workers
by: Juan Pérez-Crespo, et al.
Published: (2018)

Non Incretin Effects of DPP-4 Inhibitors: Comparative Study
by: A Shabbir Ali Bhatti, et al.
Published: (2019)

Evaluation of the University of California Diabetes Prevention Program (UC DPP) Initiative
by: Maryam Gholami, et al.
Published: (2021)

DPP4 as a Potential Candidate in Cardiovascular Disease
by: Chen SY, et al.
Published: (2022)

Chemical Exposure, Risk of Multiple Chemical Sensitivity, and Occupational Safety
by: Paolo D. Pigatto, et al.
Published: (2020)

Clinical trial simulation methods for estimating the impact of DPP-4 inhibitors on cardiovascular disease
by: Schuetz CA, et al.
Published: (2015)

Fatores que influenciam no desenvolvimento da depressão pós-parto (DPP)
by: Isadora Vilela Rodovalho, et al.
Published: (2019)

DPP9 as a Potential Novel Mediator in Gastrointestinal Virus Infection
by: Ángela del Castillo-Izquierdo, et al.
Published: (2022)

Multiple chemical sensitivity (MCS): women's health issue
by: L. Roncati, et al.
Published: (2020)

Synthesis and Anti-Diabetic Activity of an 8-Purine Derivative as a Novel DPP-4 Inhibitor in Obese Diabetic Zücker Rats
by: Chayah M, et al.
Published: (2024)

Inflammasome as an Effective Platform for Fibrosis Therapy
by: Chen TT, et al.
Published: (2021)

Antioxidant Effects of DPP-4 Inhibitors in Early Stages of Experimental Diabetic Retinopathy
by: Hugo Ramos, et al.
Published: (2022)

3D-QSAR and docking studies of arylmethylamine-based DPP IV inhibitors
by: Chaoyi Jiang, et al.
Published: (2012)

Diagnostic accuracy of DPP Fever Panel II Asia tests for tropical fever diagnosis.
by: Sandhya Dhawan, et al.
Published: (2024)

DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications?
by: Inés Valencia, et al.
Published: (2020)

DPP-IV Inhibitor-Associated Angioedema in Patient With Known History of ACE Inhibitor Angioedema
by: Chidinma Ejikeme MD, et al.
Published: (2021)

Acute Lung Injury and the NLRP3 Inflammasome
by: Gu W, et al.
Published: (2024)

The Place of DPP-4 Inhibitors in the Treatment Algorithm of Diabetes Type 2: a Systematic Review of Cost-effectiveness Studies
by: A Baptista, et al.
Published: (2019)

Caspase recruitment domain (CARD) family (CARD9, CARD10, CARD11, CARD14 and CARD15) are increased during active inflammation in patients with inflammatory bowel disease
by: Jesús K. Yamamoto-Furusho, et al.
Published: (2018)

The Effect of Using Problem Based Chemical Module Assisted by the Quartchem Card on Students Learning Outcomes and Creativity
by: Yanuar Ayu Ningtyas, et al.
Published: (2022)

Inflammasomes and dermatology
by: Daniel Coelho de Sá, et al.
Published: (2016)

Gift Card Designing
by: Lemos, Pedro J. (Pedro Joseph), 1882-1954

DPP-4 Inhibitor Linagliptin Ameliorates Oxidized LDL-Induced THP-1 Macrophage Foam Cell Formation and Inflammation
by: Wang H, et al.
Published: (2020)

The CXCR4 Ligand/Receptor Family and the DPP4 Protease in High-Risk Cardiovascular Patients
by: Jurgen Bernhagen
Published: (2016)

Acquired Haemophilia A in DPP4 Inhibitor-induced Bullous Pemphigoid as Immune Reconstitution Syndrome
by: Seiko Sugiyama, et al.
Published: (2020)

The effects of DPP-4 inhibitor on hypoxia-induced apoptosis in human umbilical vein endothelial cells
by: Akari Nagamine, et al.
Published: (2017)

Dpp4+ interstitial progenitor cells contribute to basal and high fat diet-induced adipogenesis
by: Megan Stefkovich, et al.
Published: (2021)

Quantitative Evaluation of Compliance with Recommendation for Sulfonylurea Dose Co-Administered with DPP-4 Inhibitors in Japan
by: Motonobu Sakaguchi, et al.
Published: (2012)

Increased cancer risk in HIV-infected individuals occupationally exposed to chemicals: Depression of p53 as the key driver.
by: Donald C Udah, et al.
Published: (2024)

Boswellic acid sensitizes gastric cancer cells to Cisplatin-induced apoptosis via p53-mediated pathway
by: Shadia Al-Bahlani, et al.
Published: (2020)

uL3 Regulates Redox Metabolism and Ferroptosis Sensitivity of p53-Deleted Colorectal Cancer Cells
by: Chiara Brignola, et al.
Published: (2024)

The Author Response: Risk of Multiple Chemical Sensitivity in Laboratory Workers
by: Juan Pérez Crespo, et al.
Published: (2021)

IMPACT OF NLRP3 INFLAMMASOME ON THE DEVELOPMENT OF HYPERTENSION AND RENAL AND CARDIAC HYPERTROPHY IN 2K1C AND DOCA/SALT MICE
by: Q. Wang, et al.
Published: (2012)